CAMERON MAZZA: Open Payments
NPI 1619614922 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,325 in 41 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $587 · 2025 $1,325
Food & beverage: $1,325
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $352 |
| Amgen Inc. | 4 | $295 |
| Lilly USA, LLC | 10 | $220 |
| Gilead Sciences, Inc. | 4 | $198 |
| Novo Nordisk Inc | 3 | $63 |
| PFIZER INC. | 2 | $47 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| Hologic Sales and Service, LLC | 1 | $26 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
Products named: EVENITY, MOUNJARO, AIRSUPRA, Yeztugo, BREZTRI, PREVNAR 20, GEMTESA, Kerendia.
Industry payments across CA — which companies pay providers there.
